BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//The BioCalendar - ECPv6.16.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:The BioCalendar
X-ORIGINAL-URL:https://thebiocalendar.com
X-WR-CALDESC:Events for The BioCalendar
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20230101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20230312T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20231105T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20240310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20241103T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20250309T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20251102T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240512
DTEND;VALUE=DATE:20240517
DTSTAMP:20260613T004710
CREATED:20240203T003520Z
LAST-MODIFIED:20240205T215841Z
UID:5206-1715472000-1715903999@thebiocalendar.com
SUMMARY:Biology of Cilia and Flagella
DESCRIPTION:Launched in 2007\, this conference is the leading international meeting covering all aspects of cilia and cilia-related diseases\, providing the premier forum to share the newest research. The program will cover the field from basic research in model organisms to the development of treatments for human ciliopathies.
URL:https://thebiocalendar.com/event/biology-of-cilia-and-flagella/
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240513
DTEND;VALUE=DATE:20240518
DTSTAMP:20260613T004710
CREATED:20231104T003427Z
LAST-MODIFIED:20240125T201547Z
UID:4871-1715558400-1715990399@thebiocalendar.com
SUMMARY:PEGS Boston
DESCRIPTION:PEGS Boston Summit is the Essential Industry Conference for Streamlining Biologics Development \n\n\n\n\nThe PEGS Boston Summit brings together leading experts at the forefront of biologics innovation\, providing insights into the latest technologies\, research\, and advancements in drug development\, protein and antibody engineering\, immunotherapy\, immunogenicity\, expression platforms\, multispecific antibodies\, machine learning and AI in biologics\, and more. \nPEGS Boston features main conference sessions as well as deep dive training seminars and topic-focused short courses. PEGS Boston Summit is your number one resource for protein engineering updates and is the conference to attend in 2024 to network\, collaborate\, and learn from the industry’s best.
URL:https://thebiocalendar.com/event/pegs-boston-2/
CATEGORIES:Featured
ATTACH;FMTTYPE=image/jpeg:https://thebiocalendar.com/wp-content/uploads/2024/01/p3.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240513
DTEND;VALUE=DATE:20240517
DTSTAMP:20260613T004710
CREATED:20240116T191420Z
LAST-MODIFIED:20240119T050821Z
UID:5095-1715558400-1715903999@thebiocalendar.com
SUMMARY:AAPS 2024 National Biotechnology Conference
DESCRIPTION:Tracks and Themes\nTrack 1: Advances in Discovery\, Formulation\, and Delivery of New Modalities\nA tremendous rise in the biologics market has driven significant interest in their discovery and in using novel drug delivery systems to enable drug delivery via different routes. This track focuses on aspects of the discovery and development of biologics and new modalities. Submissions are invited on topics related to multi-specific antibodies\, oligonucleotides\, proteins\, nanobodies\, genes\, RNA\, peptides\, cell-free manufactured proteins\, vaccines\, cells\, and allogenic and synthetic cells. Discussions are encouraged on diverse strategies for the discovery\, formulation\, and delivery of these modalities to address unmet medical needs. \nTheme 1: Preformulation and Formulation Approaches for Biologics and New Modalities\nKeywords: Preformulation\, Formulation\, Stability\, CMC\, Excipient\, Impurities\, Biologics\nExplore the challenges associated with preformulation and formulation development of biologics and new modalities. In addition to the modalities mentioned above under Track 1\, submissions related to screening and excipients selection\, the impact of excipients on pharmacokinetics/pharmacodynamics (PK/PD)\, and stability are welcome. Discussions of Chemistry\, Manufacturing\, and Controls (CMC) issues related to the development of these modalities are encouraged. \nTheme 2: Drug Delivery for New Modalities and Therapies\nKeywords: Drug Delivery\, Gene Delivery\, Vaccines\, Cell Therapy\, Personalized Medicine\nThis theme focuses on different strategies and challenges involved in the design of drug delivery systems\, the delivery of biologics\, and manufacturing challenges in the development of novel drug delivery systems. Topics such as nanoparticles\, liposomes\, hydrogels\, Antibody-Drug Conjugates (ADCs)\, nanobots and devices\, personalized medicines\, cell-based therapies\, and viral and non-viral gene delivery are the primary focus. Submissions on advances in the delivery of genes\, vaccines\, and biotherapeutics via non-parenteral routes of administration (e.g.\, oral\, topical\, intravitreal\, nasal\, and inhalation) are encouraged. \nTheme 3: AI/ML in Drug Discovery and Development\nKeywords: Artificial Intelligence\, Synthetic Biology\, Gene Editing\, CRISPR\, Discovery\nThis track explores how Artificial Intelligence/Machine Learning (AI/ML) and big data are transforming the landscape of drug development and reducing discovery time and cost. Submissions are welcome on novel biotherapeutics developed using AI; AI-enabled gene-editing drugs; and the combination of AI\, synthetic biology\, and cell manufacturing as well as their impact on new drugs\, novel design\, and manufacturing processes. Topics to be covered include: CMC and regulatory issues; the use of AI in CMC and process development; decentralized manufacturing\, risks\, and benefits associated with using AI in drug discovery and development; and data integrity concerns. \nTrack 2: Novel Strategies to Advance Biotherapeutic Development\nAdvances in therapeutic development for targeted delivery\, platform technology\, high-content bioanalysis\, and data science. \nTheme 1: Development Strategy for Novel Targeted Therapeutic Delivery\nKeywords: Targeted Delivery\, Bioanalysis\, Pharmacokinetics\nAs the field of targeted drug delivery advances with new modalities such as lipid nanoparticles\, cell therapies\, and gene therapeutics\, science is also gaining ground in the design of protein therapeutics tailored to deliver to specific tissues (examples: eye\, tumor\, or brain) and methods for bioanalysis. Discuss how pharmacokinetics\, pharmacodynamics\, and immunogenicity bioanalysis and data for tissue-targeted therapeutics can inform and advance therapeutic development. \nTheme 2: Advances in Analytical and Bioanalytical Platform Technology\nKeywords: Instrumentation Platforms\, Flow Cytometry\, Multiplexing\, Imaging\, Data Science\nThe field of analytical platform technology is racing to keep pace with the emergence of new modalities such as oligonucleotides and cell and gene therapies\, as well as the increasing need for more informative analytical evaluation of traditional therapeutics such as monoclonal antibodies and antibody drug conjugates. Discuss high-resolution instrumentation techniques\, multiplexing\, flow cytometry\, imaging platforms\, and other technological advancements. Submissions are also welcome related to the associated developments in data science that add increased information to biodistribution\, pharmacokinetics\, immunogenicity\, and pharmacodynamics analyses. \nTheme 3: High Content Bioanalysis\nKeywords: MAPPS\, In-Silico Prediction\, Immunogenicity Prediction\, Artificial Intelligence\, Machine Learning\, personalized medicine\, Omics\nHigh Content Bioanalysis in genomics\, proteomics\, metabolomics\, and lipidomics\, along with technologies to identify and measure biomarkers at the single cell level\, combined with advances in data sciences (artificial intelligence) are exponentially evolving. Discuss case studies and platforms for high content bioanalysis for personalized medicine\, novel -omic approaches\, immunogenicity prediction\, immunogenicity risk assessments\, and digital biomarkers. Submissions are also welcome that explore evolving data science and artificial intelligence methodologies for analysis of large data set
URL:https://thebiocalendar.com/event/aaps-2024-national-biotechnology-conference/
LOCATION:San Francisco\, CA\, San Francisco\, CA\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240513
DTEND;VALUE=DATE:20240518
DTSTAMP:20260613T004710
CREATED:20240420T042227Z
LAST-MODIFIED:20240420T042227Z
UID:5600-1715558400-1715990399@thebiocalendar.com
SUMMARY:Biotechgate Digital Partnering
DESCRIPTION:The BIOTECHGATE DIGITAL PARTNERING event series was started in spring 2020 due to the COVID-19 pandemic. We offer companies the possibility to conduct their business development and interact with partners\, clients\, licensees / licensors and suppliers in a secure\, online environment. This offer is for anybody working in business development and licensing in life sciences including biotech\, medtech\, pharma\, diagnostics\, healthtech\, suppliers\, consulting\, and not-for-profit organizations. \nParticipation is free of charge. As a member company of any of our Biotechgate partners\, you get free premium access to Biotechgate Digital Partnering. If you are not a member of any of our partners\, you can still register for free with the option to upgrade anytime.
URL:https://thebiocalendar.com/event/biotechgate-digital-partnering-3/
LOCATION:Online webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240516
DTEND;VALUE=DATE:20240517
DTSTAMP:20260613T004710
CREATED:20240327T071703Z
LAST-MODIFIED:20240327T071703Z
UID:5471-1715817600-1715903999@thebiocalendar.com
SUMMARY:US Pharma and Biotech Summit
DESCRIPTION:2024 is a pivotal year for US healthcare\, in particular for the pharma and biotech industries. A presidential election will influence crucial policies on drug pricing and health financing for years to come. AI technologies are evolving from buzzwords to making an impact in drug R&D. Pharma is facing a huge patent cliff. And the biotech market appears to be pulling out of a slump just as the US economy executes the soft landing policymakers have hoped for. \nThe Financial Times US Pharma and Biotech Summit returns to New York in May 2024\, partnered with Endpoints News for the first time. The event will gather biopharma leaders\, regulators\, investors and scientists to share unique insights about the year ahead and discuss the most important trends affecting the industry\, and the country. \nJoin us to learn how the new market cycle will finance the next period of investing in innovation. Debate the dueling approaches to the US life expectancy crisis. Hear how artificial intelligence is splitting into two technological camps. And learn how drug makers\, tech startups and insurers are fighting it out to redefine their relationship with patients.
URL:https://thebiocalendar.com/event/us-pharma-and-biotech-summit/
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240516
DTEND;VALUE=DATE:20240517
DTSTAMP:20260613T004710
CREATED:20240401T194816Z
LAST-MODIFIED:20240401T194816Z
UID:5497-1715817600-1715903999@thebiocalendar.com
SUMMARY:2024 STAT Breakthrough Summit West
DESCRIPTION:Medicine’s future\, now\n\n\nTo a person 20 years ago\, today’s medicine would seem like science fiction: routine DNA sequencing\, gene editing\, and surgery that can help an 80-year-old Mick Jagger dance. So what will the next two decades bring? We’ll peer into the mists\, looking at GLP-1 drugs for psychiatry\, a new age of individualized gene editing\, and the potential of artificial intelligence to reduce the failure rate of inventing new medicines. We’ll also check into the financial apparatus that is supposed to fund all this cool research. Join us for a series of high-level\, interactive sessions – and join the conversation. \nSan Francisco & Virtual
URL:https://thebiocalendar.com/event/2024-stat-breakthrough-summit-west/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20240516T083000
DTEND;TZID=UTC:20240516T110000
DTSTAMP:20260613T004710
CREATED:20240419T225404Z
LAST-MODIFIED:20240419T225404Z
UID:5597-1715848200-1715857200@thebiocalendar.com
SUMMARY:The Future of Life Sciences: Can Biotech Bounce Back?
DESCRIPTION:Don’t miss your chance to hear from leading Life Science and CRE experts about the state of the industry and development in Philadelphia. \nAgenda:  \n\n\n\n8:30-9:15am: Breakfast & Networking\n9:15-10am: Panel 1 with Reporter Paul Schwedelson\n10-11am: Panel 2 with Senior Reporter John George\n\n\n\nPanel 1: After developers rushed to build new lab space\, tenant demand and new development has slowed down. What does that mean for the future of Philadelphia’s life sciences sector and how will real estate developers respond? \nModerated by Reporter Paul Schwedelson \n\nNelson Way\, director of leasing and development\, Ensemble Real Estate Investments\nAnne Cummins\, co-founder and chief operating office\, Gattuso Development Partners\nPete Cramer\, vice president and market executive\, Wexford Science + Technology\nJeff DeVuono\, executive vice president\, life science division\, Brandywine Realty Trust\n\nPanel 2: The Cellicon Valley Scene: State of the life sciences industry \nModerated by Senior Reporter John George \n\nWilliam Chou\, M.D.\, CEO of Passage Bio\nBruce Levine\, Professor of gene therapy\, University of Pennsylvania\, co-founder of Capstan Therapeutics\nTiffany Wilson\, president and CEO of the University City Science Center\nLorenzo Pellegrini\, managing partner of the Hatch Biofund\nHeather A. Steinman\, Ph.D.\, MBA\, Senior Vice President for Business Development and Executive Director of Technology Transfer\, The Wistar Institute
URL:https://thebiocalendar.com/event/the-future-of-life-sciences-can-biotech-bounce-back/
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240520
DTEND;VALUE=DATE:20240521
DTSTAMP:20260613T004710
CREATED:20240507T210442Z
LAST-MODIFIED:20240507T210544Z
UID:5683-1716163200-1716249599@thebiocalendar.com
SUMMARY:H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ
DESCRIPTION:Join us for company presentations\, one-on-one investor meetings\, and meetings with H.C. Wainwright investment banking & research teams. \nWho Should Participate? \n\nPublic & private companies\nIndustry executives\nBusiness development executives\nInstitutional investors\nPrivate equity firms\nVenture capitalists
URL:https://thebiocalendar.com/event/h-c-wainwright-2nd-annual-bioconnect-investor-conference-at-nasdaq/
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240521
DTEND;VALUE=DATE:20240524
DTSTAMP:20260613T004710
CREATED:20231115T002246Z
LAST-MODIFIED:20231115T002246Z
UID:4914-1716249600-1716508799@thebiocalendar.com
SUMMARY:Pricing & Contracting USA
DESCRIPTION:Gain critical insight on regulatory requirements\, policy initiatives and best practices to enhance pricing and contracting models. Focuses include Medicaid and Government Pricing\, 340B\, Durg Pricing Transparency\, Contract and Chargeback Excellence\, and much more. Save 10% with code 24B4B10.
URL:https://thebiocalendar.com/event/pricing-contracting-usa/
ATTACH;FMTTYPE=image/jpeg:https://thebiocalendar.com/wp-content/uploads/2023/11/PricingContracting_600x176_.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240521
DTEND;VALUE=DATE:20240525
DTSTAMP:20260613T004710
CREATED:20240224T011944Z
LAST-MODIFIED:20240224T012844Z
UID:5358-1716249600-1716595199@thebiocalendar.com
SUMMARY:Nextflow Summit Boston
DESCRIPTION:We invite you to attend the Nextflow Summit Boston\, the leading event for workflow management in scientific computing and data analysis. Join us for the latest advancements and innovations in the Nextflow realm and stay at the forefront of industry developments. \nThis year\, the summit introduces an extended nf-core hackathon spanning two full days\, offering participants the opportunity for collaborative coding and networking within the community\, irrespective of their skill levels. \nMoreover\, newcomers are invited to partake in the newly introduced Nextflow and nf-core Foundational Training\, coinciding with the hackathon\, aimed at furnishing attendees with a comprehensive understanding of Nextflow and nf-core\, empowering them to build better pipelines. Whether opting for the Summit alone or both events\, attendees can tailor their experience to make the most out of their Nextflow Summit participation. \nRegister now https://hubs.la/Q02m0rvX0\n\nDates: May 21-24\nVenue: Aloft Boston Seaport District
URL:https://thebiocalendar.com/event/nextflow-summit-boston/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20240521T110000
DTEND;TZID=UTC:20240521T120000
DTSTAMP:20260613T004710
CREATED:20240501T201350Z
LAST-MODIFIED:20240501T201350Z
UID:5639-1716289200-1716292800@thebiocalendar.com
SUMMARY:Start-Up Best Practices: Foundation for a Successful Tech or Life Sciences Launch
DESCRIPTION:Welcome\, Entrepreneurs in the Tech and Life Science Markets! \n\nJoin us for our quarterly CFO Call Webinar panel to discuss essential strategies for a successful business launch. From formation and governance to launching a fundraising campaign and establishing core financial functions\, you will learn actionable insights for your organization’s growth.  \n\nTuesday\, May 21\, 11:00 AM – 12:00 PM EST \n\n\nIn today’s competitive landscape\, laying a solid foundation is crucial for your startup’s long-term success and sustainability. This webinar will highlight key strategies for thriving in the tech and life science markets\, from navigating legal complexities to understanding financial management. \n\n\nOur panel of industry experts will present highlights in key areas\, including: \n\n\nLegal Best Practices: Discover the essential legal considerations for startups\, corporate governance\, equity and debt fundraising activities\, and mergers and acquisitions. \n\n\nFinance Strategies: Gain insights into effective financial practices\, including fundraising and risk management for tech and life science startups’ unique needs. \n\n\nAccounting Practices: From budgeting to cash flow management and financial reporting\, learn actionable tips to optimize your startup’s financial health and make informed decisions to drive growth and profitability. \n\n\nWhether you’re a first-time entrepreneur or a seasoned innovator\, this is an opportunity to gain actionable insights and best practices for building a strong foundation for your business. \n\n\nPanelists:\n\n\nDan Blanchard\, Member\, Morse\nGardner Oleson\, CPA\, Technology Practice Leader\, Charles River CFO\nKevin Sarney\, CPA\, Life Science Practice Leader at Charles River CFO
URL:https://thebiocalendar.com/event/start-up-best-practices-foundation-for-a-successful-tech-or-life-sciences-launch/
LOCATION:Online webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240522
DTEND;VALUE=DATE:20240523
DTSTAMP:20260613T004710
CREATED:20240418T231356Z
LAST-MODIFIED:20240418T231356Z
UID:5592-1716336000-1716422399@thebiocalendar.com
SUMMARY:Converge Summit
DESCRIPTION:Biocom California’s Converge Summit will bring together the brightest minds in these sectors to exchange ideas\, break down barriers\, strengthen relationships\, and spark innovation. Attendees will have the chance to engage in critical conversations with industry leaders\, explore the latest research and development\, and gain valuable insights into the emerging trends and opportunities that are driving growth and innovation in the tech and healthcare sectors.
URL:https://thebiocalendar.com/event/converge-summit/
LOCATION:South San Francisco\, CA\, CA\, 94080\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240523
DTEND;VALUE=DATE:20240524
DTSTAMP:20260613T004710
CREATED:20240418T231543Z
LAST-MODIFIED:20240418T231606Z
UID:5593-1716422400-1716508799@thebiocalendar.com
SUMMARY:LABEST 2024
DESCRIPTION:The Los Angeles Bioscience Ecosystem Summit Twenty 24 (LABEST) is the premier showcase for bioscience innovation in Los Angeles County produced by UCLA Technology Development Group (UCLA TDG). This event is a collaboration of ~1\,000 participants across the Los Angeles area\, including UCLA\, Caltech\, Cal State LA\, City of Hope\, USC\, and Cedars Sinai. The event’s mission is to promote Los Angeles as a center of excellence for biotech innovation and to foster partnerships between academic institutions\, the investment community\, and the biopharma industry. \nFaculty members present their latest scientific breakthroughs\, leading to tomorrow’s critical therapies. Leading bioscience translational research programs and startups will be showcased where Southern California Institutions have significant expertise\, pioneering research\, and resource commitments directed toward developing innovative patient therapies.
URL:https://thebiocalendar.com/event/labest-2024/
LOCATION:Los Angeles\, Los Angeles\, CA\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240523T160000
DTEND;TZID=America/New_York:20240523T200000
DTSTAMP:20260613T004710
CREATED:20240404T024950Z
LAST-MODIFIED:20240521T230940Z
UID:5512-1716480000-1716494400@thebiocalendar.com
SUMMARY:BVS’ Innovation Symposium & Vendor Expo\, Cambridge
DESCRIPTION:We are very excited to announce our indoor Innovation Symposium & Vendor Expo\, Cambridge. \nThis biotech community event will bring together researchers from local biotech/pharma accounts in Cambridge/Boston and the surrounding areas to see the latest in tools\, technologies and equipment to help advance life science research. \nThis event will feature a technical presentation by QIAGEN\, vendor exhibits\, appetizers & drinks\, and lots of networking. \nComplimentary to life science job-related employees (including executives\, purchasing\, scientists\, clinical\, manufacturing\, etc.) at life science companies and research institutes. \nProduct and Service providers that sell to the life science community\, BVS and non-BVS suppliers\, lawyers\, consultants\, etc. will pay a $250.00 networking fee to attend. \nWe are looking forward to seeing everyone.
URL:https://thebiocalendar.com/event/bvs-innovation-symposium-vendor-expo-cambridge-2/
ATTACH;FMTTYPE=image/jpeg:https://thebiocalendar.com/wp-content/uploads/2024/04/SYMPOSIUM-Vendor-flyer-05-23-24-9.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240531
DTEND;VALUE=DATE:20240605
DTSTAMP:20260613T004710
CREATED:20231231T234547Z
LAST-MODIFIED:20231231T234547Z
UID:5036-1717113600-1717545599@thebiocalendar.com
SUMMARY:2024 ASCO Annual Meeting
DESCRIPTION:Attend the 2024 ASCO Annual Meeting and be part of the most significant gathering of oncology professionals worldwide\, making connections and forging collaborations that can change the landscape of cancer care. \n\n\n\n\n\n\n\n\n\n\n\nRegister for the 2024 ASCO Annual Meeting and discover state-of-the-art research\, groundbreaking treatments\, and visionary insights that will ignite your passion for oncology. This year’s program will feature over 200 sessions complementing Dr. Lynn Schuchter’s Presidential theme The Art and Science of Cancer Care: From Comfort to Cure.
URL:https://thebiocalendar.com/event/2024-asco-annual-meeting/
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240602
DTEND;VALUE=DATE:20240608
DTSTAMP:20260613T004710
CREATED:20240205T045916Z
LAST-MODIFIED:20240205T215919Z
UID:5212-1717286400-1717804799@thebiocalendar.com
SUMMARY:Nuclear Bodies: Hubs of Genomic Activity
DESCRIPTION:With a successful launch in 2022\, this conference will continue to bring together investigators across the globe focusing on molecular biology\, cell biology\, and biophysics of bodies situated within the cell nucleus. These research subjects are considered separate from the chromosomes but operate in conjunction with the genome\, including within pathological states\, with this year’s conference focusing primarily on cancer topics. 
URL:https://thebiocalendar.com/event/nuclear-bodies-hubs-of-genomic-activity/
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240603
DTEND;VALUE=DATE:20240607
DTSTAMP:20260613T004710
CREATED:20231102T210432Z
LAST-MODIFIED:20240402T210825Z
UID:4854-1717372800-1717718399@thebiocalendar.com
SUMMARY:BIO International Convention
DESCRIPTION:BUILDING CONNECTIONS\, BREAKING BARRIERS \n\n\n\nWhen the stakes are this high\, we can’t go it alone. BIO unites a global network of business leaders\, policymakers\, investors and scientists for a common purpose: curing patients\, protecting the planet\, and nourishing humanity. \nBIO 2024 is heading back West to San Diego\, CA at the San Diego Convention Center. We’re looking forward to being back together in June! \nBIO One-on-One Partnering ™ \nFind potential business partners and request meetings through our easy-to-use online system. You can expect to find senior biotech executives\, business development leaders\, and investors from premier firms participating. \nEngaging Programming \nInnovative programming around the current and future state of biotech. Including areas like therapeutic frontiers\, the business of biotech\, regulatory and policy outlooks\, and human capital.
URL:https://thebiocalendar.com/event/bio-international-convention-3/
CATEGORIES:Featured
ATTACH;FMTTYPE=image/jpeg:https://thebiocalendar.com/wp-content/uploads/2024/01/s.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20240605T130000
DTEND;TZID=UTC:20240605T140000
DTSTAMP:20260613T004710
CREATED:20240530T184615Z
LAST-MODIFIED:20240530T184615Z
UID:5790-1717592400-1717596000@thebiocalendar.com
SUMMARY:ASCO Recap\, Live!
DESCRIPTION:STAT’s reporters\, strung-out from several days of ASCO madness\, will take the virtual stage to share convention hall insights\, predictions for the months ahead\, and of course will take your audience questions live.
URL:https://thebiocalendar.com/event/asco-recap-live/
LOCATION:Online webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240609
DTEND;VALUE=DATE:20240614
DTSTAMP:20260613T004710
CREATED:20240205T050253Z
LAST-MODIFIED:20240205T220005Z
UID:5213-1717891200-1718323199@thebiocalendar.com
SUMMARY:Trace Elements in Biology and Medicine
DESCRIPTION:Since 1983\, this FASEB Science Research Conference (SRC) has been dedicated to illuminating the role of trace elements in biological systems in plants\, microbes\, and mammals. This year’s conference will bridge the gap between basic and applied science in micronutrient research. Organizers have brought together established research leaders\, new investigators\, and trainees to discuss a broad spectrum of topics in this unique area of study.
URL:https://thebiocalendar.com/event/trace-elements-in-biology-and-medicine/
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240609
DTEND;VALUE=DATE:20240614
DTSTAMP:20260613T004710
CREATED:20240205T050359Z
LAST-MODIFIED:20240205T220039Z
UID:5214-1717891200-1718323199@thebiocalendar.com
SUMMARY:Ubiquitin and Ub-like Proteins
DESCRIPTION:Since 1989\, this Science Research Conference has explored all biological and chemical aspects of UB/UBL signaling and targeted protein degradation. It is the longest-running international conference in this field that assembles a group of scientists to discuss new and exciting developments in research. The conference provides a forum for collaboration of scientists working in academic\, government\, and industrial settings to translate research advancements into novel clinical treatments. 
URL:https://thebiocalendar.com/event/ubiquitin-and-ub-like-proteins/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20240611T110000
DTEND;TZID=UTC:20240611T120000
DTSTAMP:20260613T004710
CREATED:20240529T192608Z
LAST-MODIFIED:20240529T193937Z
UID:5774-1718103600-1718107200@thebiocalendar.com
SUMMARY:Halloran’s Inspection Readiness Methodology: Failure to Plan is a Plan to Fail
DESCRIPTION:Health Authority inspections can occur anytime during a product’s lifecycle\, making preparation crucial for market approval. Tackling inspection readiness right before milestones\, like BLA or NDA submissions\, often leads to stress and avoidable findings\, delaying development. An early and ongoing inspection readiness mindset is essential for maintaining compliance and preparedness. \nJoin Halloran’s webinar and learn: \n\nIdeal inspection readiness timeline and scenarios\nInspection dos and don’ts\nInspection preparation recommendations\nCommon 483 and warning letter trends
URL:https://thebiocalendar.com/event/hallorans-inspection-readiness-methodology-failure-to-plan-is-a-plan-to-fail/
LOCATION:Online webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20240611T163000
DTEND;TZID=America/Los_Angeles:20240611T190000
DTSTAMP:20260613T004710
CREATED:20240516T015949Z
LAST-MODIFIED:20240608T000139Z
UID:5719-1718123400-1718132400@thebiocalendar.com
SUMMARY:BVS’  Biotech Community Event at SOVA Science District\, San Diego
DESCRIPTION:Our last events were a HUGE success with 300 high-quality people registering from over 100+ companies/institutes & we will once again be inviting the entire So CA Life Science Community to attend. \nThis is a special Biotech Community Event sponsored by some of the top scientific suppliers in the industry\, along with it being a wonderful way for scientists\, entrepreneurs and science vendors to network in a relaxed evening venue. \nThe event will be a combination of vendor exhibits\, tacos and beer. \nFREE to life science job-related employees (including executives\, purchasing\, scientists\, clinical\, manufacturing\, etc.) at life science companies and research institutes. \nProduct and Service providers that sell to the life science community\, BVS and non-BVS suppliers\, lawyers\, consultants\, etc. will pay a $200.00 fee to attend. \nWe look forward to seeing you there!
URL:https://thebiocalendar.com/event/bvs-biotech-community-event-at-sova-science-district-san-diego-2/
ATTACH;FMTTYPE=image/jpeg:https://thebiocalendar.com/wp-content/uploads/2024/05/BVS-Biotech-Event-Flyer-06-11-24-4.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240612
DTEND;VALUE=DATE:20240614
DTSTAMP:20260613T004710
CREATED:20240110T002744Z
LAST-MODIFIED:20240501T201859Z
UID:5066-1718150400-1718323199@thebiocalendar.com
SUMMARY:The Festival of Genomics & Biodata
DESCRIPTION:We’re looking forward to welcoming you to the Festival of Genomics & Biodata in Boston on June 12th – 13th\, 2024. The Festival is the annual get-together for the entire genomics and biodata community to discover\, meet\, learn and celebrate! \nNext year’s Festival will bring you inspirational speakers\, the latest research and clinical breakthroughs\, cutting-edge technology and incredible networking opportunities. \nFree for 90% of attendees\, the Festival is designed to help you return to work\, armed with dozens of new ideas and contacts\, but also to keep you engaged\, excited and proud of the difference your efforts make for patients.
URL:https://thebiocalendar.com/event/the-festival-of-genomics-biodata-3/
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240612
DTEND;VALUE=DATE:20240613
DTSTAMP:20260613T004710
CREATED:20240515T200718Z
LAST-MODIFIED:20240515T201017Z
UID:5716-1718150400-1718236799@thebiocalendar.com
SUMMARY:Unlocking High-Throughput Biology in Drug Discovery
DESCRIPTION:The Carterra 2024 Symposium Series is focused on high-throughput drug discovery which is enabling better medicines to be discovered faster.  Presenters to include scientists from BioStrand\, Carterra\, GSK\, Ichnos Sciences\, ImmunoPrecise Antibodies\, LifeArc\, University of Oxford\, and Wuxi Biologics. \nDiscuss the latest technologies in antibody discovery\, AI/ML\, and small molecule applications\, and network with your peers. \nJoin us at one of the locations below: \n\nOxford University\, Biochemistry Department – Oxford\, UK on June 12\, 2024\nAccelerator Utrecht – Utrecht\, Netherlands on June 14\, 2024\n\nSeating is limited and there is no cost to attend\, so register now!  We hope to see you there.
URL:https://thebiocalendar.com/event/unlocking-high-throughput-biology-in-drug-discovery/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20240613T160000
DTEND;TZID=America/Los_Angeles:20240613T190000
DTSTAMP:20260613T004710
CREATED:20240510T041845Z
LAST-MODIFIED:20240606T222510Z
UID:5699-1718294400-1718305200@thebiocalendar.com
SUMMARY:BVS and BioMed Realty’s Biotech Community Event in SSF
DESCRIPTION:We are very excited to announce BVS and BioMed Realty’s Biotech Community Event. \nWe are hosting a vendor fair at The Forum\, in the same building as Amgen and next to Genentech\, right in the heart of the large pharma/biotechs in South San Francisco. \nThe entire Bay Area Community is invited to attend & this event will be heavily advertised to all. \nThe event will be a combination of vendor exhibits\, networking\, appetizers & drinks. \nFREE to life science job-related employees (including executives\, purchasing\, scientists\, clinical\, manufacturing\, etc.) at life science companies and research institutes. \nProduct and Service providers that sell to the life science community\, BVS and non-BVS suppliers\, lawyers\, consultants\, etc. will pay a $200.00 fee to attend. \nWe look forward to seeing you there!
URL:https://thebiocalendar.com/event/bvs-and-biomed-realtys-biotech-community-event-in-ssf/
ATTACH;FMTTYPE=image/jpeg:https://thebiocalendar.com/wp-content/uploads/2024/05/Biotech-Event-Flyer-06-13-24-5.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240614
DTEND;VALUE=DATE:20240615
DTSTAMP:20260613T004710
CREATED:20240515T200858Z
LAST-MODIFIED:20240515T200927Z
UID:5717-1718323200-1718409599@thebiocalendar.com
SUMMARY:Unlocking High-Throughput Biology in Drug Discovery
DESCRIPTION:The Carterra 2024 Symposium Series is focused on high-throughput drug discovery which is enabling better medicines to be discovered faster.  Presenters to include scientists from BioStrand\, Carterra\, GSK\, Ichnos Sciences\, ImmunoPrecise Antibodies\, LifeArc\, University of Oxford\, and Wuxi Biologics. \nDiscuss the latest technologies in antibody discovery\, AI/ML\, and small molecule applications\, and network with your peers. \nJoin us at one of the locations below: \n\nOxford University\, Biochemistry Department – Oxford\, UK on June 12\, 2024\nAccelerator Utrecht – Utrecht\, Netherlands on June 14\, 2024\n\nSeating is limited and there is no cost to attend\, so register now!  We hope to see you there.
URL:https://thebiocalendar.com/event/unlocking-high-throughput-biology-in-drug-discovery-2/
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240616
DTEND;VALUE=DATE:20240621
DTSTAMP:20260613T004710
CREATED:20231231T235132Z
LAST-MODIFIED:20231231T235132Z
UID:5037-1718496000-1718927999@thebiocalendar.com
SUMMARY:DIA Global Annual Meeting
DESCRIPTION:The DIA 2024 Global Annual Meeting invites industry\, regulators\, governments\, academics\, innovators\, and patients to network\, problem-solve\, and discuss global and local challenges facing the life sciences community. Hosted in San Diego\, DIA 2024 will amplify different perspectives while highlighting expertise across the globe to reimagine current processes that better enhance health and well-being.
URL:https://thebiocalendar.com/event/dia-global-annual-meeting/
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240616
DTEND;VALUE=DATE:20240621
DTSTAMP:20260613T004710
CREATED:20240205T050504Z
LAST-MODIFIED:20240205T220119Z
UID:5215-1718496000-1718927999@thebiocalendar.com
SUMMARY:Genome Engineering: Research and Applications
DESCRIPTION:Since 2010\, this important conference continues to focus on the field of genome and epigenome editing. The meeting will focus on new tools and technologies\, understanding the biology of editors and their outcomes\, new classes of precise editors\, plant and animal modeling with precise genome editing\, and clinical trials of genome editors.
URL:https://thebiocalendar.com/event/genome-engineering-research-and-applications/
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240616
DTEND;VALUE=DATE:20240622
DTSTAMP:20260613T004710
CREATED:20240205T050738Z
LAST-MODIFIED:20240205T220248Z
UID:5217-1718496000-1719014399@thebiocalendar.com
SUMMARY:Retinal Neurobiology and Visual Processing
DESCRIPTION:For over 30 years\, this conference has brought together a group of vision scientists with diverse approaches to the latest research and technical advances exploring the relationship between the structure and function of the retina and visual processing. This year’s major themes include understanding how retinal circuits process visual information to generate unique outputs; how retinal circuitry develops; how knowledge of normal circuitry informs strategies for repair; how retinal structure and function relate to visual behavior; and discovering state-of-the-art tools to probe new functions of retinal neurons and their connections.
URL:https://thebiocalendar.com/event/retinal-neurobiology-and-visual-processing/
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240616
DTEND;VALUE=DATE:20240621
DTSTAMP:20260613T004710
CREATED:20240205T050803Z
LAST-MODIFIED:20240205T220311Z
UID:5218-1718496000-1718927999@thebiocalendar.com
SUMMARY:Channels and Transporters in Immunity
DESCRIPTION:This inaugural conference topic will examine how ion channels and transporters (ICTs) control key aspects of intracellular signaling and cell physiology. Relatively little is known about how ICTs regulate immune responses in the context of inflammation\, asthma\, allergies\, autoimmune diseases\, anti-tumor immunity\, and infection. The program will cover a range of topics including ICT functions in adaptive and innate immune cells\, ICT structure and signaling\, neuroinflammation\, cancer immunology\, and ICT immunopharmacology.
URL:https://thebiocalendar.com/event/channels-and-transporters-in-immunity/
END:VEVENT
END:VCALENDAR